Home Products DNA & RNA Nucleosides, Analogs, and Supports Nucleoside Analog Phosphoramidites RNA Nucleoside Analogs Minor RNA Phosphoramidites (TBDMS Protected) 1-Me-A-CE Phosphoramidite

1-Me-A-CE Phosphoramidite - (10-3501)

5'-Monomethoxytrityl-N6-chloroacetyl-1-methyl-Adenosine, 2'-O-TBDMS-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite

As low as $210.00

In stock

Only %1 left

default

10-3501

Product	Options
	To retrieve a catalog number, please select a pack size and format: Copy link to this configuration Size Format See Compatibility Chart 4. Select Your Quantity: Request a quote 3. Price

Product Specifications

Formula:

C₄₈H₆₃ClN₇O₇PSi

M.W.:

944.57

F.W.:

344.24

CAS Number:

434329-10-9

5'-Monomethoxytrityl-N6-chloroacetyl-1-methyl-Adenosine, 2'-O-TBDMS-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite

Description

Methylation of adenosine at position 1 produces a drastic functional change in the nucleobase. 1-Methyladenosine (pKa 8.25) is a much stronger base than adenosine (pKa 3.5). N-1 methylation excludes participation of the adenine base in canonical Watson–Crick base pairing and provides a positive charge to the nucleobase. This modification also alters the hydrophobicity of the base, the stacking properties, the ordering of water molecules and the chelation properties. The base may become involved in non-canonical hydrogen bonding, in electrostatic interactions and, in general, it may contribute to the conformational dynamics of the tRNA.

In the central dogma of molecular biology, genetic information flows from DNA to RNA and then to protein. Reversible epigenetic modifications on genomic DNA and histone have been known to substantially regulate gene expression. On the other hand, there exists more than 100 naturally occurring chemical modifications in RNA; however, the functions of these RNA modifications are largely unknown. Whether some of these modifications in RNA can be reversed and could impact gene expression in the central dogma was unknown until the recent discovery of N6-methyladenosine (N6-Me-A) as the first example of reversible RNA methylation.1 We offer the N6-Me-A RNA monomer with a phenoxyacetyl protecting group to minimize potential branching. We have shown N6-Me-A-CE Phosphoramidite to be completely compatible with all popular RNA synthesis and deprotection methods, from UltraMild to the most popular procedure using AMA for deprotection.

Details

Usage

Coupling: 15 minute coupling time recommended. Monomers that allow for UltraMILD deprotection are recommended. (Pac-A:10-3000-xx, Ac-C: 10-3015-xx, iPr-Pac-G: 10-3021-xx, U: 10-3030-xx ).
Deprotection: 2 M Ammonia in methanol, 24 hours at room temperature using UltraMILD phosphoramidites and UltraMILD Cap A is recommended. Alternatively, 60 hours at room temperature using standard phosphoramidites and Cap A will give acceptable results. To remove the 2’-TBDMS group, dry down the supernatant, treat with 1.5 mL of 1 M TBAF in THF for 18 hours at room temperature, quench with the addition of 1 mL of 1.5 M ammonium acetate and desalt (2x) using a Glen Gel-Pak™ 2.5 Desalting Column or equivalent.

Specifications
Diluent	Anhydrous Acetonitrile
Recommended Storage	Refrigerated storage, maximum of 2-8°C, dry
Stability In Solution	24 hours

Dilution/Coupling Data

The table below show pack size data and, for solutions, dilution and approximate coupling based on normal priming procedures.

ABI 392/394

Catalog #	Pack Size	Grams/Pack	0.1M Dil. (mL)	Approximate Number of Additions
				LV40	LV200	40nm	0.2μm	1μm	10μm
10-3501-02	0.25 g	.25grams	2.65	75	45	28.13	20.45	15	3.75
10-3501-90	100 µmol	.094grams	1	20	12	7.5	5.45	4	1
10-3501-95	50 µmol	.047grams	0.5	3.33	2	1.25	0.91	0.67	0.17

Expedite

Catalog #	Pack Size	Grams/Pack	Dilution (mL)	Approximate Number of Additions
				Molarity	50nm	0.2μm	1μm	15μm
10-3501-02	0.25 g	.25grams	3.95	0.07	72.6	45.38	33	4.54
10-3501-90	100 µmol	.094grams	1.5	0.07	23.6	14.75	10.73	1.48
10-3501-95	50 µmol	.047grams	0.75	0.07	8.6	5.38	3.91	0.54